Top of page
Lawyers

Jie Zhang

Lawyers

Jie Zhang

Counsel - Registered Foreign Lawyer
Corporate
Beijing

Advises corporate and private equity clients on M&A, including pre-IPO financings, buyouts, JVs, PIPEs, de-SPAC, going-private transactions and strategic investments.

Jie is counsel in our Corporate practice, currently practicing as a Registered Foreign Lawyer in Beijing. Jie’s practice focuses on advising corporate clients and private equity funds on M&A matters, including pre-IPO financings, buyouts, joint ventures, PIPEs, de-SPAC transactions, going-private transactions and strategic investments. She also advises clients on securities law and general corporate matters.

Experience

Mergers & Acquisitions
  • Going-private transactions of Hollysys Automation, Chindata Group, New Frontier Health, 51job, China Biologic Products, Sogou, Yintech and iKang Healthcare
  • Provident SPAC $1.02 billion combination with Perfect
  • UP Fintech’s $65 million convertible notes private placement
  • Acquisition by a Tencent-led consortium of a 20% equity stake in Universal Music Group from Vivendi
  • Tencent’s investment in Tuhu
  • Comcast Spectacor eSports joint venture with SK Telecom
  • Unitas Capital’s sale of Jiahao Foods to Huabao International Holdings for approximately $694 million
  • Tencent’s and Tencent Music Entertainment’s investments in Spotify, and cross-shareholding by Spotify in Tencent Music Entertainment
  • China Biologic Products’ acquisition of 80% equity interest in Tianxinfu for approximately $513 million
  • China Biologic Products’ redomiciliation from Delaware to the Cayman Islands
  • Tencent’s acquisition of China Music Corporation
  • Meituan Corporation’s strategic cooperation with DianPing
  • Origin Agritech’s sale of commercial seed production and distribution business
  • China Biologic Products’s $590 million private placement
  • Sequoia’s various investments in pre-IPO companies, including Ke, Julive and Genesis Medtech
  • Megvii Technology’s pre-IPO financing
  • iQiyi’s $1.53 billion convertible notes financing
  • Taibang Biologic Group’s $300 million equity raising
  • UCAR Technology’s $550 million Series B equity financing
  • IDG Capital Partners’ investment in SouFun
Capital Markets
  • Sinopec Group Overseas Development $3 billion senior notes offering
  • Hong Yang Group $125 million high-yield notes offering
  • Logan Property Holdings $200 and $450 million senior notes offerings
  • Shandong Yuhuang Chemical $300 million high-yield notes offering
  • China Aoyuan Property $250 Million high-yield notes offering
  • Toyota Motor Credit Corporation $750 million offering in Taiwan
  • Toyota Motor Credit Corporation $1.75 billion offering
View more experience

Education

J.D., Harvard Law School
  • cum laude
Ph.D., Cancer Biology, University of Chicago
B.S., Biological Sciences, Peking University
  • with high honors

Qualifications and admissions

  • Beijing Ministry of Justice - Registered
  • State of New York
Back to top